BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 33986739)

  • 21. Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils.
    Li C; Chen C; Kang X; Zhang X; Sun S; Guo F; Wang Q; Kou X; Bai W; Zhao A
    Hum Reprod; 2020 Dec; 35(12):2677-2691. PubMed ID: 33067638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloid-derived suppressor cells from tumour-bearing mice induce the population expansion of CD19
    Chen W; Ning X; Liu Y; Shen T; Liu M; Yin H; Ding Y; Zhou J; Yin R; Cai L; Wu Y; Qian L
    Immunology; 2024 May; 172(1):127-143. PubMed ID: 38332630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accumulation of blood-circulating PD-L1-expressing M-MDSCs and monocytes/macrophages in pretreatment ovarian cancer patients is associated with soluble PD-L1.
    Okła K; Rajtak A; Czerwonka A; Bobiński M; Wawruszak A; Tarkowski R; Bednarek W; Szumiło J; Kotarski J
    J Transl Med; 2020 Jun; 18(1):220. PubMed ID: 32487171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toll-like receptor 7 agonist imiquimod prevents the progression of SLE in MRL/lpr mice via inhibiting the differentiation of T follicular helper cells.
    Duan X; Shen C; Zhang X; Wu L; Chen J; Ma B; Wang Q; Sun P; Lan Y; Su C
    Int Immunopharmacol; 2020 Mar; 80():106239. PubMed ID: 32007709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arginase-1-dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus.
    Wu H; Zhen Y; Ma Z; Li H; Yu J; Xu ZG; Wang XY; Yi H; Yang YG
    Sci Transl Med; 2016 Mar; 8(331):331ra40. PubMed ID: 27009269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus.
    Han X; Vesely MD; Yang W; Sanmamed MF; Badri T; Alawa J; López-Giráldez F; Gaule P; Lee SW; Zhang JP; Nie X; Nassar A; Boto A; Flies DB; Zheng L; Kim TK; Moeckel GW; McNiff JM; Chen L
    Sci Transl Med; 2019 Dec; 11(522):. PubMed ID: 31826980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.
    Flores-Toro JA; Luo D; Gopinath A; Sarkisian MR; Campbell JJ; Charo IF; Singh R; Schall TJ; Datta M; Jain RK; Mitchell DA; Harrison JK
    Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1129-1138. PubMed ID: 31879345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PD-1 Signaling Promotes Tumor-Infiltrating Myeloid-Derived Suppressor Cells and Gastric Tumorigenesis in Mice.
    Kim W; Chu TH; Nienhüser H; Jiang Z; Del Portillo A; Remotti HE; White RA; Hayakawa Y; Tomita H; Fox JG; Drake CG; Wang TC
    Gastroenterology; 2021 Feb; 160(3):781-796. PubMed ID: 33129844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silica Exposure Differentially Modulates Autoimmunity in Lupus Strains and Autoantibody Transgenic Mice.
    Foster MH; Ord JR; Zhao EJ; Birukova A; Fee L; Korte FM; Asfaw YG; Roggli VL; Ghio AJ; Tighe RM; Clark AG
    Front Immunol; 2019; 10():2336. PubMed ID: 31632407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent lentivirus infection induces early myeloid suppressor cells expansion to subvert protective memory CD8 T cell response
    Liu L; Lin Q; Peng J; Fang J; Tan Z; Tang H; Kwan K; Nishiura K; Liang J; Kwok H; Du Z; Sun J; Liu K; Yuen KY; Wang H; Chen Z
    EBioMedicine; 2020 Oct; 60():103008. PubMed ID: 32979832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloid-derived suppressor cells regulate the immunosuppressive functions of PD-1
    Liu M; Wei F; Wang J; Yu W; Shen M; Liu T; Zhang D; Wang Y; Ren X; Sun Q
    Cell Death Dis; 2021 May; 12(5):465. PubMed ID: 33967272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids.
    Koh V; Chakrabarti J; Torvund M; Steele N; Hawkins JA; Ito Y; Wang J; Helmrath MA; Merchant JL; Ahmed SA; Shabbir A; Yan So JB; Yong WP; Zavros Y
    Cancer Lett; 2021 Oct; 518():59-71. PubMed ID: 34126195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Egr2-independent, Klf1-mediated induction of PD-L1 in CD4
    Teruya S; Okamura T; Komai T; Inoue M; Iwasaki Y; Sumitomo S; Shoda H; Yamamoto K; Fujio K
    Sci Rep; 2018 May; 8(1):7021. PubMed ID: 29728568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TIGIT/CD155 blockade enhances anti-PD-L1 therapy in head and neck squamous cell carcinoma by targeting myeloid-derived suppressor cells.
    Mao L; Xiao Y; Yang QC; Yang SC; Yang LL; Sun ZJ
    Oral Oncol; 2021 Oct; 121():105472. PubMed ID: 34333450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of myeloid-derived suppressor cell function by valproic acid enhanced anti-PD-L1 tumor immunotherapy.
    Adeshakin AO; Yan D; Zhang M; Wang L; Adeshakin FO; Liu W; Wan X
    Biochem Biophys Res Commun; 2020 Feb; 522(3):604-611. PubMed ID: 31785814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-type lectin receptor Dectin3 deficiency balances the accumulation and function of FoxO1-mediated LOX-1
    Li D; Lu L; Kong W; Xia X; Pan Y; Li J; Wang J; Wang T; Liang J; Dou H; Hou Y
    Cell Death Dis; 2021 Sep; 12(9):829. PubMed ID: 34480018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma.
    Loeuillard E; Yang J; Buckarma E; Wang J; Liu Y; Conboy C; Pavelko KD; Li Y; O'Brien D; Wang C; Graham RP; Smoot RL; Dong H; Ilyas S
    J Clin Invest; 2020 Oct; 130(10):5380-5396. PubMed ID: 32663198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloid-Derived Suppressive Cell Expansion Promotes Melanoma Growth and Autoimmunity by Inhibiting CD40/IL27 Regulation in Macrophages.
    Valencia JC; Erwin-Cohen RA; Clavijo PE; Allen C; Sanford ME; Day CP; Hess MM; Johnson M; Yin J; Fenimore JM; Bettencourt IA; Tsuneyama K; Romero ME; Klarmann KD; Jiang P; Bae HR; McVicar DW; Merlino G; Edmondson EF; Anandasabapathy N; Young HA
    Cancer Res; 2021 Dec; 81(23):5977-5990. PubMed ID: 34642183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations.
    Fabian KP; Padget MR; Donahue RN; Solocinski K; Robbins Y; Allen CT; Lee JH; Rabizadeh S; Soon-Shiong P; Schlom J; Hodge JW
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32439799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Niclosamide suppresses the expansion of follicular helper T cells and alleviates disease severity in two murine models of lupus via STAT3.
    Jang SG; Lee J; Hong SM; Song YS; Kim MJ; Kwok SK; Cho ML; Park SH
    J Transl Med; 2021 Feb; 19(1):86. PubMed ID: 33632240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.